Issue29February 2024 - April 2024 Celltrion Launches Zymfentra, a Subcutaneous Form of Infliximab Celltrion USA introduces Zymfentra, the first...
Issue28October 2023 - December 2023 FDA to form advisory committee for digital health and AI The FDA plans to establish a new advisory committee...
Issue27June 2023 - August 2023 Why Recent Regulatory Changes Require a Deeper Focus on Health Equity The 2023 EY Health Equity Outlook Report...
Issue26January 2023 - February 2023 J&J’s Latest Data for Nipocalimab in Fetal Disorder Suggests Momenta Acquisition May Still Pay Off When...
Issue25October 2021 - December 2021 Israel to Share Data with Pfizer in Exchange for COVID-19 Vaccine Doses Merck Says Antiviral Pill Is...
Issue24July 2021 - September 2021 FDA Revises Labeling of Biogen’s Alzheimer’s Drug to Emphasize Early Treatment The Food and Drug...
Issue23December 2020 - February 2021 Israel to Share Data with Pfizer in Exchange for COVID-19 Vaccine Doses Israel has committed to send Pfizer...
Issue22September 2020 - November 2020 Serum Institute of India Initiates Manufacturing of Codagenix’s Intranasal Live-Attenuated COVID-19...
Issue21January 2020 - April 2020 Boehringer Tngelheim, Enleofen Tnk $1B-Per-Product Anti-TL-11 Partnership Focused on NASH, Lung Disorders...
Issue20September 2019 - December 2019 In Stunning Twist, FDA Approves Sarepta’s Duchenne Drug It Rejected The Food and Drug Administration...